Although Exubera is turning out to be a flop, you can’t say it’s not good for something. Turns out it’s good for disciplining deadbeat husbands, fighting off dogs while jogging, and rolling dough.
According to analysts, Pfizer was slow to market with Exubera, initially assigning it to a sales team that was not prepared to explain it to doctors, and then not beginning to advertise it until this summer. Some doctors complain the Exubera inhaler costs too much and isn’t covered by many insurers. It also looks like something you would find in a college frat house.
Pfizer vice chairman David Shedlarz responded to this uproar by saying, “Exubera was not our finest day. We made a lot of mistakes with what is a profoundly important therapeutic.”
[Update: Neglected to mention our blatant ripoff of Pharma Giles. We hope this link helps get you back up to #30 in the rankings ]
Search Blog Posts
Our Healthcare100 Ranking
Tagsadverse drug reactions Affordable Care Act big pharma Canadian drugs canadian pharmacies canadian pharmacy consumer reports Dave Ramsey discount drugs divine healing Drug costs drug prices Drug reimportation eDrugSearch.com FDA Fosamax healing scriptures Health 2.0 health blog directory health blogs healthcare100 healthcare reform Hypertension Jehova Rophe Jesus Christ Lipitor Medi Share miracles Obamacare online pharmacy dictionary osteoporosis Pharmacies pharmacy spam phrma Prescription drugs promote health blog Proverbs 3:5-8 reimportation relenza Roche saving money submit health blog Tamiflu The Great Physician The Lord our Healer